|
|
|
|
||
Some insight into behind-the-scenes negotiationshttps://endpts.com/partnering-talks-led-to-biogens-800m-nightstar-buyout-as-players-clustered-around-the-hot-deal-table-for-gene-therapies/ BIOPHARMADIVE chart Competition for gene therapy buyouts yields hefty premiums Takeout price (total value) Premium over prior day's close # of interested parties Novartis-AveXis $218 per share ($8.7 billion) 88% 3 (incl. offers from all 3) Roche-Spark $114.50 per share ($4.8 billion) 120% 2* (incl. offers from both) Biogen-Nightstar $25.50 per share ($800 million) 68% 4 (incl. offers from 2) *A third proposed a collaboration with $450 million upfront SOURCE: SEC filings |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
27018 | Re: Some insight into behind-the-scenes negotiations | priceless | 1 | 3/21/2019 11:41:23 AM |